PREDICTORS OF LITHIUM PROPHYLAXIS EFFECTIVENESSSARANTIDIS D; WATERS B.1981; PROG. NEURO-PSYCHOPHARMACOL.; ISSN 0364-7722; USA; DA. 1981; VOL. 5; NO 5-6; PP. 507-510; BIBL. 10 REF.Article

DETERMINATION OF THE OPTIMAL CONCENTRATION OF LITHIUM FOR THE PROPHYLAXIS OF MANIC-DEPRESSIVE DISORDERWATERS B; LAPIERRE Y; GAGNON A et al.1982; BIOL. PSYCHIATRY; ISSN 0006-3223; USA; DA. 1982; VOL. 17; NO 11; PP. 1323-1329; BIBL. 14 REF.Article

Alprazolam and amitriptyline in the treatment of moderate depressionLAPIERRE, Y. D; BROWNE, M; OYEWUMI, K et al.International clinical psychopharmacology. 1994, Vol 9, Num 1, pp 41-45, issn 0268-1315Article

Levels of anxiety, depression and denial in patients with myocardial infarctionSARANTIDIS, D; THOMAS, A; IPHANTIS, K et al.European psychiatry. 1997, Vol 12, Num 3, pp 149-151, issn 0924-9338Article

Platelet MAO activity in patients with dysthymic disorderTRIPODIANAKIS, J; MARKIANOS, M; SARANTIDIS, D et al.Psychiatry research. 1998, Vol 78, Num 3, pp 173-178, issn 0165-1781Article

Treatment of major affective disorder with fluvoxamineLAPIERRE, Y. D; BROWNE, M; HORN, E et al.The Journal of clinical psychiatry. 1987, Vol 48, Num 2, pp 65-68, issn 0160-6689Article